Trial Profile
A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Mar 2014
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Substance-related disorders
- Focus Therapeutic Use
- 29 Mar 2014 New trial record